Arcosa (ACA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Aug, 2026Executive summary
A special meeting is scheduled for September 4, 2026, for shareholders to vote on a proposed merger with CRH Americas, Inc., where the company would become a wholly owned subsidiary of CRH.
Litigation and multiple demand letters have been filed by shareholders alleging insufficient disclosures in the proxy materials; the company disputes these claims but issued supplemental disclosures to mitigate risk and avoid delays.
The company provided additional financial analyses and clarified methodologies used by its financial advisors, Evercore and Goldman Sachs, regarding the fairness of the merger consideration.
Forward-looking statements highlight risks related to the merger, including regulatory approvals, litigation, transaction costs, and operational disruptions.
Voting matters and shareholder proposals
Shareholders are asked to vote on the adoption and approval of the merger agreement at a virtual special meeting.
Board of directors and corporate governance
No new or amended employment, compensation, or other agreements have been entered into by directors or executive officers in connection with the merger.
The merger is not conditioned on any post-closing employment or equity participation by current management.
Latest events from Arcosa
- Stockholders to vote on $150/share all-cash acquisition by CRH, pending Q1 2027 close.ACA
Proxy filing - Revenue and profit rose, with strategic divestiture and a pending merger defining the quarter.ACA
Q2 2026 - Shareholders to vote on $150/share all-cash merger, with board and advisors supporting approval.ACA
Proxy filing - Shareholders to vote on a $150/share all-cash merger, with board unanimous support and appraisal rights.ACA
Proxy filing - Stavola acquisition accelerates infrastructure focus, margin growth, and long-term value creation.ACA
Sidoti September Small-Cap Virtual Conference - CRH’s $8.5B acquisition of Arcosa offers a 25% premium and accelerates infrastructure growth.ACA
Proxy filing - Arcosa to be acquired by CRH for $8.5B, with shareholders receiving $150 per share.ACA
Proxy filing - Definitive agreement for acquisition by CRH announced, pending shareholder approval in Q1 2027.ACA
Proxy filing - Adjusted EBITDA up 26% and margin expands, with 2025 guidance reaffirmed amid resilient markets.ACA
Q1 2025